Načítá se...

Neurophysiological Biomarkers of Parkinson’s Disease

BACKGROUND: There is a need for reliable and robust Parkinson’s disease biomarkers that reflect severity and are sensitive to disease modifying investigational therapeutics. OBJECTIVE: To demonstrate the utility of EEG as a reliable, quantitative biomarker with potential as a pharmacodynamic endpoin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Parkinsons Dis
Hlavní autoři: Waninger, Shani, Berka, Chris, Stevanovic Karic, Marija, Korszen, Stephanie, Mozley, P. David, Henchcliffe, Claire, Kang, Yeona, Hesterman, Jacob, Mangoubi, Tomer, Verma, Ajay
Médium: Artigo
Jazyk:Inglês
Vydáno: IOS Press 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7242849/
https://ncbi.nlm.nih.gov/pubmed/32116262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-191844
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!